China Spacesat Co.,Ltd. Stock price

Equities

600118

CNE000000SM3

Aerospace & Defense

End-of-day quote Shanghai S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
25.53 CNY +3.44% Intraday chart for China Spacesat Co.,Ltd. -2.48% -1.12%
Sales 2023 * 7.06B 976M Sales 2024 * 8.15B 1.13B Capitalization 29.18B 4.04B
Net income 2023 * 290M 40.12M Net income 2024 * 351M 48.56M EV / Sales 2023 * 4.14 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 3.58 x
P/E ratio 2023 *
103 x
P/E ratio 2024 *
82.3 x
Employees 3,772
Yield 2023 *
0.32%
Yield 2024 *
0.32%
Free-Float 47.43%
More Fundamentals * Assessed data
Dynamic Chart
China Spacesat Co.,Ltd.(SHSE:600118) added to Shanghai Stock Exchange 180 Value Index CI
China Spacesat Co.,Ltd.(SHSE:600118) added to SSE 180 Index CI
China Spacesat Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
China Spacesat Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
China Spacesat Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
China Spacesat Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
China Spacesat Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
China Resources Double-Crane Pharmaceutical Co.,Ltd. acquired 50.1% stake in Shenzhou Biology & Technology Co., Ltd from Aerospace Shenzhou Biology & Technology Group Co., Ltd , China Aerospace Investment Holdings Ltd , China Spacesat Co.,Ltd. and Beijing Dawn Aerospace Bio-tech Co., Ltd. CI
China Spacesat Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
China Resources Double-Crane Pharmaceutical Co.,Ltd. agreed to acquire 50.1% stake in Shenzhou Biology & Technology Co., Ltd. for approximately CNY 500 million. CI
China Spacesat Co.,Ltd.(SHSE:600118) dropped from SSE 180 Index CI
China Spacesat Co.,Ltd.(SHSE:600118) dropped from Shanghai Stock Exchange 180 Value Index CI
China Spacesat Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
China Spacesat Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Aerospace Shenzhou Smart System Technology Co., Ltd. announced that it has received CNY 82.43 million in funding from China Spacesat Co.,Ltd. CI
More news
1 day-5.33%
1 week-5.73%
Current month-4.04%
1 month-6.41%
3 months-1.16%
6 months-1.79%
Current year-4.42%
More quotes
1 week
24.66
Extreme 24.66
26.69
1 month
24.66
Extreme 24.66
26.69
Current year
20.37
Extreme 20.37
26.85
1 year
20.37
Extreme 20.37
31.97
3 years
16.38
Extreme 16.38
34.78
5 years
16.38
Extreme 16.38
45.97
10 years
14.83
Extreme 14.83
81.90
More quotes
Managers TitleAgeSince
Director of Finance/CFO 45 21-11-04
President 46 21-06-28
Corporate Officer/Principal 54 17-05-17
Members of the board TitleAgeSince
Director/Board Member 56 21-06-28
Director/Board Member 61 09-08-09
Chairman 56 22-06-14
More insiders
Date Price Change Volume
24-03-27 25.53 +3.44% 16 583 960
24-03-27 24.68 -5.33% 17,871,150
24-03-26 26.07 +1.40% 22,118,680
24-03-25 25.71 +1.30% 20,796,620
24-03-22 25.38 -3.06% 13,125,410

End-of-day quote Shanghai S.E., March 26, 2024

More quotes
China Spacesat Co Ltd is a China-based company principally engaged in aerospace manufacturing and satellite applications. The aerospace manufacturing business mainly includes satellite system development and aerospace component manufacturing. The satellite application business mainly includes satellite application technology equipment manufacturing and satellite application services. The Company mainly operates its businesses in China, with North, Northwest and South China as its main market.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
24.68
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock
  2. Equities
  3. Stock China Spacesat Co.,Ltd. - Shanghai S.E.